Clinical Finance: Key Strategies to Stay in Control of Your Study Budget
All too often, clinical study budgets mean unpredictability, scope creep, and vendors in the driver’s seat. What if budget management didn’t have to be the most dreaded part of your job? In this session, we will cover key strategies to help keep you in control of your budget. This combination of essential knowledge, tools, and process recommendations will strengthen your budget management capabilities and leave you feeling more confident in your monthly finance meetings.
Whether you are kicking off a new project, trying to regain control of ongoing study financials, or just trying to gain best practices, this session will help reduce unpredictable scope increases and “wow” change orders, keeping you on top of your budget through your trial.
By attending this session, you will:
- Gain an understanding of clinical trial cost drivers and algorithm-based budgets
- Obtain fundamental information to support effective forecasting within your department
- Provide clarity on when to bring financials to the decision-making table
- Optimize your financial tracking and reporting capabilities and partnerships with CROs
- Highlight simple yet effective operational tweaks to help streamline your budgeting processes
This course will be of benefit to anyone involved in clinical trials a global or domestic scale. This session is specifically beneficial for study and program managers and any other staff member involved with clinical budgeting and/or financial forecasting for trial activities.
Dyana Boutwell is a Principal Consultant at Halloran Consulting Group, Inc. She focuses on clinical and medical affairs business operations, project management, evidence-based strategic and financial planning, process development, and functional gap analyses. Dyana has over 13 years of experience in research and development, with broad experience that spans across various aspects of development operations management and planning.
Prior to joining Halloran, Dyana was the Associate Director of Clinical Operations at Vertex Pharmaceuticals, where she worked closely with senior leadership, franchise and program leads on development and continuous improvement of clinical planning processes and operational project management practices. She also led the analytics and financial forecasting functions, overseeing the collection, analysis, and reporting of portfolio, program, functional and study-level metrics as well as program/study budgeting, scenario planning, and financial modeling. Dyana also has experience managing process optimization projects through automation and technology implementation and has successfully integrated new roles, procedures, and systems into cross-functional business operations.
Prior to her experience in clinical research, Dyana was a bench scientist in both an R&D and quality control/GMP laboratory.
Dyana earned a Master of Business Administration from University of Massachusetts, Amherst and a Bachelor of Science in Chemistry from Newberry College in Newberry, South Carolina.